ACM
Argent Capital Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.1M | Hold |
14,080
| – | – | 0.03% | 99 |
|
|
2025
Q1 | $1.02M | Hold |
14,080
| – | – | 0.03% | 101 |
|
|
2024
Q4 | $1.04M | Sell |
14,080
-2,120
| -13% | -$157K | 0.03% | 105 |
|
|
2024
Q3 | $1.07M | Sell |
16,200
-856
| -5% | -$56.5K | 0.03% | 97 |
|
|
2024
Q2 | $1.58M | Hold |
17,056
| – | – | 0.05% | 88 |
|
|
2024
Q1 | $1.63M | Sell |
17,056
-113
| -0.7% | -$10.8K | 0.05% | 88 |
|
|
2023
Q4 | $1.31M | Hold |
17,169
| – | – | 0.04% | 91 |
|
|
2023
Q3 | $1.19M | Hold |
17,169
| – | – | 0.04% | 92 |
|
|
2023
Q2 | $1.62M | Hold |
17,169
| – | – | 0.05% | 92 |
|
|
2023
Q1 | $1.42M | Buy |
17,169
+969
| +6% | +$80.2K | 0.05% | 96 |
|
|
2022
Q4 | $1.21M | Hold |
16,200
| – | – | 0.04% | 99 |
|
|
2022
Q3 | $1.34M | Hold |
16,200
| – | – | 0.05% | 100 |
|
|
2022
Q2 | $1.54M | Hold |
16,200
| – | – | 0.06% | 95 |
|
|
2022
Q1 | $1.91M | Hold |
16,200
| – | – | 0.06% | 94 |
|
|
2021
Q4 | $2.1M | Hold |
16,200
| – | – | 0.06% | 92 |
|
|
2021
Q3 | $1.83M | Hold |
16,200
| – | – | 0.06% | 94 |
|
|
2021
Q2 | $1.68M | Hold |
16,200
| – | – | 0.05% | 99 |
|
|
2021
Q1 | $1.36M | Hold |
16,200
| – | – | 0.05% | 104 |
|
|
2020
Q4 | $1.48M | Hold |
16,200
| – | – | 0.05% | 103 |
|
|
2020
Q3 | $1.29M | Hold |
16,200
| – | – | 0.05% | 118 |
|
|
2020
Q2 | $1.12M | Buy |
16,200
+10,800
| +200% | +$747K | 0.05% | 125 |
|
|
2020
Q1 | $1.02M | Buy |
+5,400
| New | +$1.02M | 0.05% | 123 |
|